NightHawk Biosciences(NHWK) - 2023 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 7, 2024 Scorpius Holdings, Inc. (Exact name of registrant as specified in charter) Delaware (Registrant's telephone number including area code) NightHawk Biosciences, Inc. (Former Name and Former Address) Check the appropriate box below if the Form 8-K filing is intended to simultaneously ...